Healthcare -
Biotechnology - NASDAQ - US
$ 6.02
-3.06 %
$ 1.83 B
Market Cap
-4.07
P/E
IOVA - STOCK-BASED COMPENSATION
Stock-based Compensation IOVA - Iovance Biotherapeutics, Inc.
62.6 M
LAST VALUE
-5.26%
2 YEAR CAGR
25.61%
5 YEAR CAGR
12.27%
10 YEAR CAGR